Table I.
lncRNA MYU | |||||
---|---|---|---|---|---|
Clinicopathological features | Number of patients | High expression | Low expression | χ2 value | P-value |
Age (years) | 0.169 | 0.681 | |||
<60 | 34 | 18 | 16 | ||
≥60 | 78 | 38 | 40 | ||
Sex | 1.885 | 0.170 | |||
Male | 71 | 32 | 39 | ||
Female | 41 | 24 | 17 | ||
Histological grade | 4.390 | 0.036 | |||
High + moderate | 63 | 26 | 37 | ||
Low | 49 | 30 | 19 | ||
Vascular tumour thrombus | 0.728 | 0.393 | |||
Present | 30 | 17 | 13 | ||
Absent | 82 | 39 | 43 | ||
T classification | 5.659 | 0.059 | |||
T1 | 29 | 9 | 20 | ||
T2 | 36 | 20 | 16 | ||
T3 | 47 | 27 | 20 | ||
Lymph node metastasis | 6.196 | 0.013 | |||
Present | 47 | 30 | 17 | ||
Absent | 65 | 26 | 39 | ||
TNM stage | 5.486 | 0.019 | |||
I/II | 70 | 29 | 41 | ||
III/IV | 42 | 27 | 15 |
Statistical analyses were performed by using Pearson's χ2 test. lncRNA, long non-coding RNA; MYU, c-Myc upregulated lncRNA.